Cargando…
Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists
Continuously reducing excess blood glucose is a primary goal for the management of type 2 diabetes (T2D). Most patients with T2D require glucose-lowering medications to achieve and maintain adequate glycemic control; however, treatment failure may occur, limiting treatment options. Glucagon-like pep...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357070/ https://www.ncbi.nlm.nih.gov/pubmed/28331351 http://dx.doi.org/10.2147/DMSO.S126763 |